Search research articles
Contact Us
Filters
Showing results (71-80 of 209) with videos related to
Page
of 21
Sort By:
Annals of Hepatology
|
December 4, 2024
Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
Jacob Romano, Jessica Burnside, Giada Sebastiani, et al.
British Journal of Clinical Pharmacology
|
August 19, 2021
Utilization and long-term persistence of direct oral anticoagulants among patients with nonvalvular atrial fibrillation and liver disease
Antonios Douros, Ying Cui, Robert W Platt, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
May 5, 2025
Sex differences in the prevalence and cardiometabolic risk profiles of steatotic liver disease: A Canadian Longitudinal Study on Aging analysis
Jessica Burnside, Felice Cinque, Giada Sebastiani, et al.
Hepatology International
|
May 8, 2024
MAFLD identifies patients with significant hepatic fibrosis better than MASLD
Ziyan Pan, Said A Al-Busafi, Maheeba Abdulla, et al.
Canadian Journal of Gastroenterology & Hepatology
|
January 14, 2014
Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey
Giada Sebastiani, Peter Ghali, Phil Wong, et al.
Thrombosis Research
|
March 29, 2024
Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study
Antonios Douros, Ying Cui, Robert W Platt, et al.
Atherosclerosis
|
March 24, 2024
Metabolic dysfunction-associated steatotic liver disease: An opportunity for collaboration between cardiology and hepatology
Paolo Raggi, Jovana Milic, Marcella Manicardi, et al.
International Journal of Molecular Sciences
|
August 26, 2022
Cannabinoids and Chronic Liver Diseases
Ralph-Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, et al.
The International Journal on Drug Policy
|
May 2, 2018
Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review
Nadine Kronfli, Blake Linthwaite, Fiona Kouyoumdjian, et al.
Canadian Liver Journal
|
July 18, 2025
Validation of FIB-4 for the Diagnosis of Liver Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Chinmay Bera, Nashla Hamdan-Perez, Heather Mary-Kathleen Kosick, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 209) with videos related to
Sort By:
Page
of 21
Annals of Hepatology
|
December 4, 2024
Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
Jacob Romano, Jessica Burnside, Giada Sebastiani, et al.
British Journal of Clinical Pharmacology
|
August 19, 2021
Utilization and long-term persistence of direct oral anticoagulants among patients with nonvalvular atrial fibrillation and liver disease
Antonios Douros, Ying Cui, Robert W Platt, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
May 5, 2025
Sex differences in the prevalence and cardiometabolic risk profiles of steatotic liver disease: A Canadian Longitudinal Study on Aging analysis
Jessica Burnside, Felice Cinque, Giada Sebastiani, et al.
Hepatology International
|
May 8, 2024
MAFLD identifies patients with significant hepatic fibrosis better than MASLD
Ziyan Pan, Said A Al-Busafi, Maheeba Abdulla, et al.
Canadian Journal of Gastroenterology & Hepatology
|
January 14, 2014
Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey
Giada Sebastiani, Peter Ghali, Phil Wong, et al.
Thrombosis Research
|
March 29, 2024
Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study
Antonios Douros, Ying Cui, Robert W Platt, et al.
Atherosclerosis
|
March 24, 2024
Metabolic dysfunction-associated steatotic liver disease: An opportunity for collaboration between cardiology and hepatology
Paolo Raggi, Jovana Milic, Marcella Manicardi, et al.
International Journal of Molecular Sciences
|
August 26, 2022
Cannabinoids and Chronic Liver Diseases
Ralph-Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, et al.
The International Journal on Drug Policy
|
May 2, 2018
Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review
Nadine Kronfli, Blake Linthwaite, Fiona Kouyoumdjian, et al.
Canadian Liver Journal
|
July 18, 2025
Validation of FIB-4 for the Diagnosis of Liver Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Chinmay Bera, Nashla Hamdan-Perez, Heather Mary-Kathleen Kosick, et al.
Page
of 21